INTRODUCTION
During the last four years GSI has developed a procedure for cancer treatment by means of the intensity controlled rasterscan-method. This method includes active variations of beam parameters during the treatment session and the integration of 'on-Iine'PET monitoring.
Starting in 1997 several patients have been successfully treated within this GSI experimental cancer treatment program. The developments and experiences of this program accompanied by intensive discussions with the medical community led to a proposal for a hospital based light ion accelerator facility for the clinic in Heidelberg.
V I
The main characteristics of this facility are the application of the rasterscan method with active intensity-, energy-, and beamsize-variation in combination with the usage of isocentric light ion gantries. The accelerator is designed to accelerate both low LET ions (p, He) and high LET ions (C, 0) to cover the specific medical requirements. Major aspects of the design are influenced from the experiences of the GSI cancer treatment program; the requirements of this facility, however, exceed in many fields those of this GSI therapy program.
REQUIREMENTS
The basis of the accelerator concept has to satisfy the demands of the medical community for the treatment procedures. One of the key aspects of the proposed facility is the use of the intensity controlled rasterscan technique (Fig. l) , which is a novel treatment concept, developed at GSI and successfully applied within patient treatments of the GSI pilot project.
Fig. 1 Rasterscan-Method
The accelerated and slowly extracted beam enters 2 fast scanner magnets, that deflect the beam both in horizontal and vertical direction to cover the lateral dimensions of the tumor. Ionization chambers in front of the patient measure the number of ions at a specific irradiation point and control the scanner excitation. Fast multiwire proportional counters detect the position and beam width at each scanning point. When a required dose limit has been reached the beam extraction is interrupted very fast (< 0.5 ms).
Whereas at presently existing therapy-dedicated protonand light-ion accelerators for cancer treatment the beamparameters are constant over the treatment interval, this method demands fast, active energy-variation to achieve different penetration depths and intensity-variation to minimize the treatment time [l] . The main requirements of the proposed facility were intensively discussed with radiotherapists and biophysicists and can be summarized as follows: For the synchrotron with a circumference of about 64 meters 6 bending magnets with a maximum flux density of 1.6 T and a doublet focusing structure are proposed. 6 long drift spaces are available for the installation of injection and extraction elements and the RF-cavity. After a 15 turn injection, corresponding to an injection time of 30 ps, the acceleration takes place within 0.5 s.
For slow extraction with variable extraction time between I and 10 s and multiple beam extraction.at the same flat top the 'transverse knock out' method is proposed.
d) High energy beam transoort
The high energy beam transport system leads the slowly extracted beam either to a beam dump or distributes it to three treatment places. Just after the synchrotron extraction section a fast deflecting magnet will prohibit the beam delivery in case of interlocks.
e) Treatment areas In order to meet the demand for a patient flow of 1000 patientdyear three treatment areas are foreseen. For the first area the beam will be delivered from a horizontal beam line, similar to that used at the GSI pilot project. The beam for the second and third treatment places will be delivered by a rotating beam transport system ('isocentric gantry'). All beam lines are equipped with horizontal and vertical scanning magnets and beam dignostic devices for the intensity controlled rasterscan. The integration of PET monitoring systems both in the horizontal and the gantry beam lines is proposed as well.
Gantrv beam lines Fig. 3 : Layout of the isocentric Gantry A strong demand of the medical community is the installation of two gantry beamlines for irradiation angles between 0 and 360 degree. An isocentric gantry type with two 42 and one 90 degree bending magnets is proposed , in which the horizontal and vertical scanning magnets are located upstream before the last 90 degree deflection magnet in order to minimize the gantry-radius.
The irraddiation field is 20 * 20 cm2,
The total length of this gantry is about 20 m and the outer radius 6.3 m. In order to limit the concrete shielding the counterweight of the mechanical rotator also serves as a radiation shielding.
A special ion optics is used which provides an achromatic beam transport to the treatment location independent from the gantry angle. In addition a constant beam diameter is achieved for different horizontal and vertical beam emittances. 
STATUS
To a certain extend the proposed projects benefits from the experiences that have been achieved within the GSI pilot therapy project. .The principles of the accelerator control based on the usage of approved settings, stored in nonvolatile memories will probably transferred. The demonstrated long term stability of the beam position (see Fig. 5 ) could be further improved with a moderate position feed back beam by means of the fast position monitors and the rasterscan-magnets. .The intensity controlled rastercan-technique has been approved within a large number of treatment fractions applied to patients. Despite the strong intensity modulation of the spill the requested dose uniformity could be reliably achieved. .The 'on-line' Positron-Emission Tomography (PET) has proved to be a valuable diagnostic tool for dose verification. The application of this method to the isocentric gantry is under investigation. *Most of the anticipated test procedures both at the accelerator and the treatment place have been evaluated.
At GSI for the proposed facility various ion optical design studies and first design studies of critical elements have been performed. These investigations concern all accelerator sections from the source to the treatment caves. 
